Back to Archived Journals » Core Evidence » Volume 2 » Issue 4

Review

Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration

       
Total article views   HTML views PDF downloads Totals
8,246 Dovepress* 8,246+ 2,280 10,526
Totals 8,246 2,280 10,526
*Since 15 December 2007
+Since July 2016

View citations on Google Scholar